Costly GLP-1 drug use for weight loss has soared, study reports
- Americans' use of GLP-1 drugs like Ozempic for weight loss dramatically increased between 2018 and 2022.
- This surge happened as GLP-1 drugs are costly, often running close to $1,000 or more monthly.
- Michelle Dowsey led a study providing the first characterization of GLP-1 use among individuals without diabetes.
- In 2022, spending on these drugs reached $5.8 billion, averaging $1,540 per prescription, while patients paid about $35 out-of-pocket.
- Researchers aim to guide debates on balancing healthcare spending with accessibility of GLP-1 medications, as only 1 in 250 adults used them in 2022.
26 Articles
26 Articles
Feinsinger column: Ozempic and other GLP-1 weight-loss drugs
Dr. Michael Greger is famous for several books including “How Not to Die,” and for his website nutritionfacts.org. He recently wrote a primer on the new injectable weight loss drugs: “Ozempic, Risks, Benefits, and Natural Alternatives to GLP-1 Weight-Loss Drugs.” This column is a summary. What is GLP-1? GLP-1 is short for glucagon-like peptide-1, which is one of the 20 or more peptide hormones secreted by cells lining our digestive tract that c…
Here's how much Ozempic and similar drugs have soared in popularity since 2018
The use of GLP-1 meds — made popular by Ozempic (NVO) — among U.S. adults without diabetes more than tripled between 2018 and 2022, with annual spending surging from $1.6 billion to $5.8 billion.Read more...
Coverage Details
Bias Distribution
- 83% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage